Matches in SemOpenAlex for { <https://semopenalex.org/work/W3211279595> ?p ?o ?g. }
- W3211279595 endingPage "305" @default.
- W3211279595 startingPage "271" @default.
- W3211279595 abstract "In this chapter the use of nanomaterials (e.g., graphene oxide, quantum dots, silver, zinc oxide, and gold nanoparticles) to combat COVID-19 is presented. This chapter does not include nanomaterials used for the release of drugs or antiviral molecules where the nanomaterial is not a part of the antiviral effect. The nanomaterials presented somehow interact with the virus, therefore, having an antiviral effect per se. The chapter first reviews the updated efforts conducted evaluating nanomaterials against SARS-CoV-2. Later, the chapter reviews nanomaterials that have been evaluated against enveloped viruses (e.g., the feline coronavirus, influenza A virus, pseudorabies virus, herpes simplex virus, and respiratory syncytial virus), which could be tested against SARS-CoV-2. Most of the nanomaterials studied thus far are effective at inhibiting viruses when contacting them with the virus before infection. Incipient studies address the use of nanomaterials in therapeutic approaches. Similarly, most studies of nanomaterials against viruses have only been evaluated in vitro. Few studies have been conducted in vivo using mice. Virus inactivation is generally achieved by the interaction of the nanomaterial and the virus through electrostatic, hydrophobic, and affinity interactions. A combination of these interactions could arise depending on the properties of the nanomaterial. In few stances the nanomaterial studied responds to an external stimulation, such as near-infrared irradiation, to inactivate the virus. Finally, some works evaluate or envision the nanomaterials as antiviral agents of surfaces or components of personal protection equipment." @default.
- W3211279595 created "2021-11-08" @default.
- W3211279595 creator A5044960714 @default.
- W3211279595 date "2022-01-01" @default.
- W3211279595 modified "2023-10-18" @default.
- W3211279595 title "Antivirals based on nanomaterials against SARS-CoV-2" @default.
- W3211279595 cites W1829304243 @default.
- W3211279595 cites W1963859626 @default.
- W3211279595 cites W1966980337 @default.
- W3211279595 cites W1970290419 @default.
- W3211279595 cites W1973681903 @default.
- W3211279595 cites W1990681348 @default.
- W3211279595 cites W1991796071 @default.
- W3211279595 cites W1994682335 @default.
- W3211279595 cites W1994744102 @default.
- W3211279595 cites W1997479687 @default.
- W3211279595 cites W1998720810 @default.
- W3211279595 cites W2000043459 @default.
- W3211279595 cites W2002566079 @default.
- W3211279595 cites W2008332711 @default.
- W3211279595 cites W2013920162 @default.
- W3211279595 cites W2014875584 @default.
- W3211279595 cites W2016113010 @default.
- W3211279595 cites W2016231286 @default.
- W3211279595 cites W2022742170 @default.
- W3211279595 cites W2028848055 @default.
- W3211279595 cites W2029802274 @default.
- W3211279595 cites W2034996626 @default.
- W3211279595 cites W2036922937 @default.
- W3211279595 cites W2039294169 @default.
- W3211279595 cites W2040373128 @default.
- W3211279595 cites W2041032377 @default.
- W3211279595 cites W2041478066 @default.
- W3211279595 cites W2046997174 @default.
- W3211279595 cites W2050307916 @default.
- W3211279595 cites W2052407829 @default.
- W3211279595 cites W2054970259 @default.
- W3211279595 cites W2055222641 @default.
- W3211279595 cites W2055295979 @default.
- W3211279595 cites W2064611989 @default.
- W3211279595 cites W2064860382 @default.
- W3211279595 cites W2066499253 @default.
- W3211279595 cites W2068581949 @default.
- W3211279595 cites W2078351845 @default.
- W3211279595 cites W2080536284 @default.
- W3211279595 cites W2080927210 @default.
- W3211279595 cites W2089309601 @default.
- W3211279595 cites W2089676546 @default.
- W3211279595 cites W2090592501 @default.
- W3211279595 cites W2091362446 @default.
- W3211279595 cites W2096793204 @default.
- W3211279595 cites W2097406561 @default.
- W3211279595 cites W2104154679 @default.
- W3211279595 cites W2104777023 @default.
- W3211279595 cites W2107513109 @default.
- W3211279595 cites W2110167136 @default.
- W3211279595 cites W2113733844 @default.
- W3211279595 cites W2114982232 @default.
- W3211279595 cites W2117622131 @default.
- W3211279595 cites W2133262997 @default.
- W3211279595 cites W2138141675 @default.
- W3211279595 cites W2143627435 @default.
- W3211279595 cites W2143910776 @default.
- W3211279595 cites W2144966860 @default.
- W3211279595 cites W2145617208 @default.
- W3211279595 cites W2145628992 @default.
- W3211279595 cites W2150441957 @default.
- W3211279595 cites W2151671351 @default.
- W3211279595 cites W2158508516 @default.
- W3211279595 cites W2160790707 @default.
- W3211279595 cites W2225281217 @default.
- W3211279595 cites W2250024711 @default.
- W3211279595 cites W2315962575 @default.
- W3211279595 cites W2316689999 @default.
- W3211279595 cites W2322658347 @default.
- W3211279595 cites W2326973281 @default.
- W3211279595 cites W2335171656 @default.
- W3211279595 cites W2336560014 @default.
- W3211279595 cites W2344462922 @default.
- W3211279595 cites W2413422179 @default.
- W3211279595 cites W2510633501 @default.
- W3211279595 cites W2519349851 @default.
- W3211279595 cites W2520033800 @default.
- W3211279595 cites W2530605349 @default.
- W3211279595 cites W2551555727 @default.
- W3211279595 cites W2560348876 @default.
- W3211279595 cites W2563829531 @default.
- W3211279595 cites W2568433184 @default.
- W3211279595 cites W2586506325 @default.
- W3211279595 cites W2589585246 @default.
- W3211279595 cites W2590086682 @default.
- W3211279595 cites W2605763140 @default.
- W3211279595 cites W2733708744 @default.
- W3211279595 cites W2735191928 @default.
- W3211279595 cites W2747001756 @default.
- W3211279595 cites W2756273202 @default.
- W3211279595 cites W2777208753 @default.
- W3211279595 cites W2783702966 @default.